HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Javier Pastor Selected Research

posaconazole

10/2012Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole.
7/2012Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.
5/2012In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.
3/2012Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
8/2011Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
2/2011In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex.
10/2010Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii.
9/2010Experimental murine scedosporiosis: histopathology and azole treatment.
7/2010Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species.
5/2010Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Javier Pastor Research Topics

Disease

43Infections
10/2014 - 03/2002
10Body Weight (Weight, Body)
03/2013 - 06/2003
5scedosporiosis
09/2010 - 06/2003
2Mycoses (Diseases, Fungus)
10/2014 - 09/2007
2Aspergillosis
10/2012 - 02/2011
2Chromoblastomycosis (Chromomycosis)
03/2012 - 08/2011
2Zygomycosis (Phycomycosis)
08/2009 - 10/2008
2Trichosporonosis
06/2006 - 02/2005
1Phaeohyphomycosis
07/2010
1Cryptococcosis
07/2007
1Central Nervous System Infections (Central Nervous System Infection)
07/2007

Drug/Important Bio-Agent (IBA)

21Amphotericin B (Amphotericin)FDA LinkGeneric
02/2014 - 12/2004
17posaconazoleFDA Link
10/2012 - 10/2008
16Voriconazole (Vfend)FDA LinkGeneric
09/2013 - 12/2003
7liposomal amphotericin BFDA Link
01/2011 - 03/2002
6Pharmaceutical PreparationsIBA
03/2013 - 09/2007
5Micafungin (FK463)FDA Link
05/2009 - 02/2005
4Itraconazole (Sporanox)FDA LinkGeneric
03/2012 - 02/2010
3Fluconazole (Zonal)FDA LinkGeneric
02/2014 - 02/2005
3AzolesIBA
09/2013 - 09/2010
3AnidulafunginFDA Link
04/2012 - 03/2011
3Terbinafine (Lamisil)FDA LinkGeneric
03/2012 - 01/2011
3TriazolesIBA
03/2012 - 06/2003
3deoxycholate drug combination amphotericin BIBA
12/2009 - 12/2004
2Caspofungin (Cancidas)FDA Link
02/2014 - 09/2013
2Dihydrotachysterol (AT 10)IBA
08/2011 - 06/2006
2Flucytosine (Ancobon)FDA Link
02/2009 - 11/2005
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2004 - 03/2002
1MannansIBA
11/2011
1polyglucosanIBA
11/2011
1EchinocandinsIBA
12/2009
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2009
1Interferon-gamma (Interferon, gamma)IBA
08/2009
1Antifungal AgentsIBA
10/2003
1albaconazoleIBA
06/2003

Therapy/Procedure

12Therapeutics
10/2014 - 03/2002